Tim Lau
Research Classification
Research Interests
Infectious diseases
Antimicrobial Stewardship
systematic reviews
Clinical Pharmacokinetics
Clinical Pharmacy
Research Options
I am available and interested in collaborations (e.g. clusters, grants).
I am interested in and conduct interdisciplinary research.
I am interested in working with undergraduate students on research projects.
Research Methodology
Systematic Reviews
Publications
- Reduced fixed dose tocilizumab 400 mg IV compared to weight-based dosing in critically ill patients with COVID-19: A before-after cohort study (2022)
The Lancet Regional Health - Americas, - A canadian perspective on the revised 2020 ashp-idsa-pids-sidp guidelines for vancomycin auc-based therapeutic drug monitoring for serious mrsa infections (2021)
JAMMI, 6 (1), 3-9 - Safety of administering cefazolin versus other antibiotics in penicillin-allergic patients for surgical prophylaxis at a major Canadian teaching hospital. (2021)
Surgery, - What Is the Evidence for Co-trimoxazole, Clindamycin, Doxycycline, and Minocycline in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Pneumonia? (2019)
The Annals of pharmacotherapy, - Ammi canada position statement on asymptomatic bacteriuria (2018)
JAMMI, 3 (1), 4-7 - Effect of an antimicrobial stewardship programme on antimicrobial utilisation and costs in patients with leukaemia: a retrospective controlled study (2018)
Clinical Microbiology and Infection, 24 (8), 882-888 - Funding for Antimicrobial Stewardship Programs: A Customizable Business Case Template. (2018)
The Canadian journal of hospital pharmacy, 71 (1), 50-51 - Non-standard treatment for uncomplicated Chlamydia trachomatis urogenital infections: a systematic review. (2018)
BMJ open, - Perceptions of Hospital Pharmacists Concerning Clinical Research: A Survey Study. (2018)
The Canadian journal of hospital pharmacy, 71 (2), 105-110 - Treatment of Acute Epididymitis: A Systematic Review and Discussion of the Implications for Treatment Based on Etiology. (2018)
Sexually transmitted diseases, - A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies. (2017)
Drugs in R&D, - Combination of Ceftriaxone and Ampicillin for the Treatment of Enterococcal Endocarditis: A Qualitative Systematic Review. (2017)
The Annals of pharmacotherapy, - Roles of Infectious Diseases Consultant Pharmacists and Antimicrobial Stewardship Pharmacists: A Survey of Canadian Tertiary Care Academic Hospitals. (2017)
The Canadian journal of hospital pharmacy, - Acute Kidney Injury With Tobramycin-Impregnated Bone Cement Spacers in Prosthetic Joint Infections. (2015)
The Annals of pharmacotherapy, - Critical appraisal of clinical practice guidelines in pediatric infectious diseases. (2015)
International journal of clinical pharmacy, - Evaluation of a Clostridium difficile infection management policy with clinical pharmacy and medical microbiology involvement at a major Canadian teaching hospital (2015)
Journal of Clinical Pharmacy and Therapeutics, 40 (6), 655-660 - Horizontal infection prevention measures and a risk-managed approach to vancomycin-resistant enterococci: An evaluation. (2015)
American journal of infection control, - Mobilising for safer care: Addressing structural barriers to reducing healthcare-associated infections in Vancouver, Canada (2015)
Health Sociology Review, 24 (2), 137-151 - Vancomycin loading doses: a systematic review. (2015)
The Annals of pharmacotherapy, - Antimicrobial co-resistance patterns of gram-negative bacilli isolated from bloodstream infections: a longitudinal epidemiological study from 2002-2011. (2014)
BMC infectious diseases, - Evaluation of a Once-Daily Vancomycin Regimen in an Outpatient Leukemia/Bone Marrow Transplant Clinic (OD-VANCO Study). (2014)
The Canadian journal of hospital pharmacy, - Identification of risk factors for nephrotoxicity in patients receiving extended-duration, high-trough vancomycin therapy. (2014)
The Canadian journal of hospital pharmacy, - Addition of rifampin to vancomycin for methicillin-resistant Staphylococcus aureus infections: what is the evidence? (2013)
The Annals of pharmacotherapy, - Serotonergic and adrenergic drug interactions associated with linezolid: A critical review andpractical management approach,Interacciones de medicamentos con linezolid que resultan en reacciones serotonérgicas y adrenérgicas: Una revisión crítica y acerca (2013)
Annals of Pharmacotherapy, 47 (4), 543-560 - Development and validation of a novel vancomycin dosing nomogram for achieving high-target trough levels at 2 canadian teaching hospitals. (2012)
The Canadian journal of hospital pharmacy, - Drug use evaluation of moxifloxacin (avelox) using a hand-held electronic device at a canadian teaching hospital. (2012)
P & T : a peer-reviewed journal for formulary management, 37 (5), 291-299 - Mosquirix (RTS,S): A novel vaccine for the prevention of Plasmodium falciparum malaria,Mosquirix (RTS,S): Un nouveau vaccine pour la prévention de la malaria à Plasmodium falciparum (2012)
Annals of Pharmacotherapy, 46 (3), 384-393 - Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria. (2012)
The Annals of pharmacotherapy, - CSHP Professional Practice Conference 2011: Poster Abstracts / Conférence sur la pratique professionnelle 2011 de la SCHP : Résumés des affiches. (2011)
The Canadian journal of hospital pharmacy, - Vancomycin-induced neutropenia: is it dose- or duration-related? (2011)
The Annals of pharmacotherapy, - The Travel and Tropical Medicine Manual, 4th Edition. (2009)
The Canadian journal of hospital pharmacy, - Physician perceptions of enhanced community pharmacist care in cholesterol management: A survey of physicians contacted during the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP) (2005)
Canadian Pharmaceutical Journal, 138 (4), 33-39 - The impact of a pharmacist-managed dosage form conversion service on ciprofloxacin usage at a major Canadian teaching hospital: a pre- and post-intervention study. (2005)
BMC health services research, - Does ketamine have a role in managing severe exacerbation of asthma in adults? (2001)
Pharmacotherapy, 21 (9 I), 1100-1106 - Identification of the TIMP-2 binding site on the gelatinase A hemopexin C-domain by site-directed mutagenesis and the yeast two-hybrid system (1999)
Annals of the New York Academy of Sciences, 878, 747-753 - Identification of the tissue inhibitor of metalloproteinases-2 (TIMP-2) binding site on the hemopexin carboxyl domain of human gelatinase A by site- directed mutagenesis: The hierarchical role in binding TIMP-2 of the unique cationic clusters of hemopexin (1999)
Journal of Biological Chemistry, 274 (7), 4421-4429
If this is your researcher profile you can log in to the Faculty & Staff portal to update your details and provide recruitment preferences.
